Bohl CE - Search Results

1

Characterization of the in vitro metabolism of selective androgen receptor modulator using human, rat, and dog liver enzyme preparations.

Gao W, Wu Z, Bohl CE, Yang J, Miller DD, Dalton JT. Gao W, et al. Among authors: bohl ce. Drug Metab Dispos. 2006 Feb;34(2):243-53. doi: 10.1124/dmd.105.007112. Epub 2005 Nov 4. Drug Metab Dispos. 2006. PMID: 16272404 Free PMC article.

2

A selective androgen receptor modulator for hormonal male contraception.

Chen J, Hwang DJ, Bohl CE, Miller DD, Dalton JT. Chen J, et al. Among authors: bohl ce. J Pharmacol Exp Ther. 2005 Feb;312(2):546-53. doi: 10.1124/jpet.104.075424. Epub 2004 Sep 3. J Pharmacol Exp Ther. 2005. PMID: 15347734

3

Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.

Bohl CE, Miller DD, Chen J, Bell CE, Dalton JT. Bohl CE, et al. J Biol Chem. 2005 Nov 11;280(45):37747-54. doi: 10.1074/jbc.M507464200. Epub 2005 Aug 29. J Biol Chem. 2005. PMID: 16129672 Free PMC article.

4

Chemistry and structural biology of androgen receptor.

Gao W, Bohl CE, Dalton JT. Gao W, et al. Among authors: bohl ce. Chem Rev. 2005 Sep;105(9):3352-70. doi: 10.1021/cr020456u. Chem Rev. 2005. PMID: 16159155 Free PMC article. Review. No abstract available.

5

In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.

Chen J, Hwang DJ, Chung K, Bohl CE, Fisher SJ, Miller DD, Dalton JT. Chen J, et al. Among authors: bohl ce. Endocrinology. 2005 Dec;146(12):5444-54. doi: 10.1210/en.2005-0732. Epub 2005 Sep 15. Endocrinology. 2005. PMID: 16166218 Free PMC article.

6

Preclinical pharmacology of a nonsteroidal ligand for androgen receptor-mediated imaging of prostate cancer.

Yang J, Bohl CE, Nair VA, Mustafa SM, Hong SS, Miller DD, Dalton JT. Yang J, et al. Among authors: bohl ce. J Pharmacol Exp Ther. 2006 Apr;317(1):402-8. doi: 10.1124/jpet.105.094334. Epub 2006 Jan 24. J Pharmacol Exp Ther. 2006. PMID: 16434567

7

Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.

Bohl CE, Wu Z, Chen J, Mohler ML, Yang J, Hwang DJ, Mustafa S, Miller DD, Bell CE, Dalton JT. Bohl CE, et al. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5567-70. doi: 10.1016/j.bmcl.2008.09.002. Epub 2008 Sep 5. Bioorg Med Chem Lett. 2008. PMID: 18805694 Free PMC article.

8

A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor.

Bohl CE, Chang C, Mohler ML, Chen J, Miller DD, Swaan PW, Dalton JT. Bohl CE, et al. J Med Chem. 2004 Jul 15;47(15):3765-76. doi: 10.1021/jm0499007. J Med Chem. 2004. PMID: 15239655 Free PMC article.

9

Structural basis for antagonism and resistance of bicalutamide in prostate cancer.

Bohl CE, Gao W, Miller DD, Bell CE, Dalton JT. Bohl CE, et al. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):6201-6. doi: 10.1073/pnas.0500381102. Epub 2005 Apr 15. Proc Natl Acad Sci U S A. 2005. PMID: 15833816 Free PMC article.

10

Domain structure and DNA binding regions of beta protein from bacteriophage lambda.

Wu Z, Xing X, Bohl CE, Wisler JW, Dalton JT, Bell CE. Wu Z, et al. Among authors: bohl ce. J Biol Chem. 2006 Sep 1;281(35):25205-14. doi: 10.1074/jbc.M512450200. Epub 2006 Jul 3. J Biol Chem. 2006. PMID: 16820360 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters